JohnRandolphForehandMD

PubMed

• 65 citations
  Clinical Features and Current Management of Chronic Granulomatous Disease
  Christopher B. Forrest, John R. Forehand, Richard A. Axtell, Robert L. Roberts, Richard B. Johnston> ;Hematology/oncology Clinics of North America. 1988 Jun 1
• Phospholipase A2 activity in human neutrophils. Stimulation by lipopolysaccharide and possible involvement in priming for an enhanced respiratory burst.
  Forehand, J. R., Johnston, R. B., Bomalaski, J. S.> ;J Immunol. 1993 Nov 1
• Chronic granulomatous disease: newly defined molecular abnormalities explain disease variability and normal phagocyte physiology.
  Forehand, J. R., Johnston, R. B.> ;Curr Opin Pediatr. 1994 Dec
• Priming of neutrophils and macrophages for enhanced release of superoxide anion by the calcium ionophore ionomycin. Implications for regulation of the respiratory burst.
  Finkel, T. H., Pabst, M. J., Suzuki, H., Guthrie, L. A., Forehand, J. R., Phillips, W. A., Johnston, R. B.> ;J Biol Chem. 1987 Sep 15
• Lipopolysaccharide priming of human neutrophils for an enhanced respiratory burst. Role of intracellular free calcium.
  Forehand, J. R., Pabst, M. J., Phillips, W. A., Johnston, R. B.> ;J Clin Invest. 1989 Jan
• Mechanisms of host defense against Candida species. II. Biochemical basis for the killing of Candida by mononuclear phagocytes.
  Maródi, L., Forehand, J. R., Johnston, R. B.> ;J Immunol. 1991 Apr 15
• Mechanisms of lipopolysaccharide priming for enhanced respiratory burst activity in human neutrophils.
  Forehand, J. R., Bomalski, J. S., Johnston, R. B.> ;Adv Exp Med Biol. 1991
• Join now to see all